Inventor · disambiguated record
Jean-Pierre Kinet
Also filed as: KINET JEAN P · KINET JEAN-PIERRE
26 granted patents·48 pending applications·637 citations·filing 1988–2020
96Inventor score
Top patents by PatentIndex Score
74 records- 0192US10092564B2Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulationAB SCIENCE·Filed 2017·Granted Oct 9, 2018·11 cites·20 claims
- 0292US7026283B2Calcium-independent negative regulation by CD81 of receptor signallingBETH ISRAEL HOSPITAL·Filed 2001·Granted Apr 11, 2006·33 cites·16 claims
- 0389US8450302B22-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitorsCIUFOLINI MARCO·Filed 2011·Granted May 28, 2013·8 cites·7 claims
- 0480US9078894B2Treatment of severe persistant asthma with masitinibMOUSSY ALAIN·Filed 2012·Granted Jul 14, 2015·2 cites·17 claims
- 0580US8227470B2Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitorsMOUSSY ALAIN·Filed 2008·Granted Jul 24, 2012·1 cites·17 claims
- 0675US5403264AEndoscopic closure inspection deviceETHICON INC·Filed 1993·Granted Apr 4, 1995·201 cites·12 claims
- 0773US5639660APolypeptide and DNA sequence corresponding to the human receptor with high affinity for IgEHOFFMANN LA ROCHE·Filed 1988·Granted Jun 17, 1997·22 cites·7 claims
- 0872US5545123ASurgical lift method and apparatusETHICON INC·Filed 1994·Granted Aug 13, 1996·134 cites·13 claims
- 0971US5770396AIsolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin EUS HEALTH·Filed 1992·Granted Jun 23, 1998·22 cites·20 claims
- 1069US7811568B2Smallpox monoclonal antibodyQuercegen Pharma·Filed 2007·Granted Oct 12, 2010·2 cites·11 claims
- 1162US7700610B2Use of tyrosine kinase inhibitors for treating allergic diseasesAB SCIENCE·Filed 2002·Granted Apr 20, 2010·1 cites·2 claims
- 1262US7678805B2Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD)AB SCIENCE·Filed 2002·Granted Mar 16, 2010·1 cites·4 claims
- 1360US5405351AEndoscopic loop including an applying instrumentETHICON ENDO SURGERY·Filed 1993·Granted Apr 11, 1995·90 cites·7 claims
- 1459US5415160ASurgical lift method and apparatusETHICON INC·Filed 1994·Granted May 16, 1995·71 cites·4 claims
- 1558US2009082360A1Use of tyrosine kinase inhibitors for treating CNS disordersAB SCIENCE·Filed 2008·Application pending·0 cites
- 1655US8906357B2Treatment of multiple sclerosis with masitinibMOUSSY ALAIN·Filed 2011·Granted Dec 9, 2014·0 cites·24 claims
- 1754US10238649B2Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factorsAB SCIENCE·Filed 2013·Granted Mar 26, 2019·0 cites·11 claims
- 1854US6423501B2Calcium-independent negative regulation by CD81 of receptor signalingBETH ISRAEL HOSPITAL·Filed 1997·Granted Jul 23, 2002·7 cites·2 claims
- 1952US2023023935A1Use of masitinib for the treatment of eosinophilic asthmaAB SCIENCE·Filed 2020·Application pending·0 cites
- 2052US2016263110A1Use of masitinib for treatment of amyotrophic lateral sclerosisAB SCIENCE·Filed 2014·Application pending·0 cites
- 2151US2017196853A1Use of an inhibitor of kinase activity, particularly masitinib, for treatment of prostate cancerAB SCIENCE·Filed 2014·Application pending·0 cites
- 2251US2005074850A1Novel calcium channels and uses thereofSYNTA PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 2351US2008199457A1Anti-CD63 antibodies and methods of use thereofKRAFT STEFAN·Filed 2007·Application pending·0 cites
- 2450US2007249628A1Use of Mast Cells Inhibitors for Treating Patients Exposed to Chemical or Biological WeaponsMOUSSY ALAIN·Filed 2005·Application pending·0 cites
- 2550US2004242601A1Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitisFiled 2002·Application pending·0 cites
- 2650US2008004279A1Use of C-Kit Inhibitors for Treating Plasmodium Related DiseasesMOUSSY ALAIN·Filed 2005·Application pending·0 cites
- 2749US5965605AInhibition of the binding human IgE to its receptor by tetracyclic compounds for the alleviation of IgE-mediated immune responseHESKA CORP·Filed 1997·Granted Oct 12, 1999·15 cites·24 claims
- 2849US2016244845A1Method for determining the prognosis of pancreatic cancerAB SCIENCE·Filed 2014·Application pending·0 cites
- 2949US2004266797A1Use of potent,selective and non toxic c-kit inhibitors for treating tumor angiogensisFiled 2002·Application pending·0 cites
- 3049US2004259892A1Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms)Filed 2002·Application pending·0 cites
- 3148US2005222091A1Use of tyrosine kinase inhibitors for treating cns disordersMOUSSY ALAIN·Filed 2003·Application pending·0 cites
- 3247US2014051662A1Treatment of multiple myeloma with masitinibMOUSSY ALAIN·Filed 2012·Application pending·0 cites
- 3347US2007032521A1Use of c-kit inhibitors for treating type II diabetesAB SCIENCE·Filed 2004·Application pending·0 cites
- 3446US2014147415A1Treatment of mastocytosis with masitinibMOUSSY ALAIN·Filed 2011·Application pending·0 cites
- 3546US2008025916A1Tailored Treatment Suitable for Different Forms of MastocytosisAB SCIENCE·Filed 2004·Application pending·0 cites
- 3646US2007191267A1Use of tyrosine kinase inhibitors for treating cerebral ischemiaAB SCIENCE·Filed 2004·Application pending·0 cites
- 3745US12472164B2Masitinib for the treatment of sickle cell diseaseAB SCIENCE·Filed 2020·Granted Nov 18, 2025·0 cites·17 claims
- 3845US2005203098A1Use of tyrosine kinase inhibitors for treating substance use disordersFiled 2003·Application pending·0 cites
- 3945US2006182745A1Anti-CD63 antibodies and methods of use thereofKRAFT STEFAN·Filed 2006·Application pending·0 cites
- 4044US10045978B2Treatment of mastocytosis with masitinibAB SCIENCE·Filed 2015·Granted Aug 14, 2018·0 cites·18 claims
- 4144US2008207572A1Use of Dual C-Kit/Fgfr3 Inhibitors for Treating Multiple MyelomaAB SCIENCE·Filed 2006·Application pending·0 cites
- 4243US7741335B2Use of tyrosine kinase inhibitors for treating inflammatory diseasesAB SCIENCE·Filed 2002·Granted Jun 22, 2010·0 cites·1 claims
- 4343US2005089838A1Method for identifying compounds that specifically deplete mast cellsFiled 2002·Application pending·0 cites
- 4443US2006265769A1Gab2 (p97) gene and methods of use thereofBETH ISRAEL HOSPITAL·Filed 2005·Application pending·0 cites
- 4542US6165799ADetection of anti-Fc.sub.ε R autoantibodies in asthmaticsHESKA CORP·Filed 1997·Granted Dec 26, 2000·8 cites·5 claims
- 4642US2005176687A1Use of tyrosine kinase inhibitors for treating autoimmune diseasesFiled 2002·Application pending·0 cites
- 4742US2013072474A1Treatment of dementia of alzheimer's type with masitinibKINET JEAN-PIERRE·Filed 2011·Application pending·0 cites
- 4842US2004266771A1Use of tyrosine kinase inhibitors for treating bone lossFiled 2002·Application pending·0 cites
- 4942US2008096227A1CRAC modulators and use of same for drug discoveryPENNER REINHOLD·Filed 2007·Application pending·0 cites
- 5042US2004241226A1Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infectionsFiled 2002·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →